220 related articles for article (PubMed ID: 8759351)
1. Characterization of ocular hypertension induced by adenosine agonists.
Crosson CE; Gray T
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1833-9. PubMed ID: 8759351
[TBL] [Abstract][Full Text] [Related]
2. Adenosine receptor activation modulates intraocular pressure in rabbits.
Crosson CE
J Pharmacol Exp Ther; 1995 Apr; 273(1):320-6. PubMed ID: 7714784
[TBL] [Abstract][Full Text] [Related]
3. Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys.
Tian B; Gabelt BT; Crosson CE; Kaufman PL
Exp Eye Res; 1997 Jun; 64(6):979-89. PubMed ID: 9301479
[TBL] [Abstract][Full Text] [Related]
4. Modulation of intraocular pressure by adenosine agonists.
Crosson CE; Gray T
J Ocul Pharmacol; 1994; 10(1):379-83. PubMed ID: 8207340
[TBL] [Abstract][Full Text] [Related]
5. Contributions of adenosine receptor activation to the ocular actions of epinephrine.
Crosson CE; Petrovich M
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2054-61. PubMed ID: 10440261
[TBL] [Abstract][Full Text] [Related]
6. Ocular hypotensive activity of the adenosine agonist (R)-phenylisopropyladenosine in rabbits.
Crosson CE
Curr Eye Res; 1992 May; 11(5):453-8. PubMed ID: 1606841
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
Webb RL; Barclay BW; Graybill SC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2 receptor function in rat ventricular myocytes.
Dobson JG; Fenton RA
Cardiovasc Res; 1997 May; 34(2):337-47. PubMed ID: 9205548
[TBL] [Abstract][Full Text] [Related]
9. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
Ogidigben M; Chu TC; Potter DE
J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
[TBL] [Abstract][Full Text] [Related]
10. Intraocular pressure responses to the adenosine agonist cyclohexyladenosine: evidence for a dual mechanism of action.
Crosson CE
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1837-40. PubMed ID: 11431451
[TBL] [Abstract][Full Text] [Related]
11. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
Casati C; Monopoli A; Dionisotti S; Zocchi C; Bonizzoni E; Ongini E
J Pharmacol Exp Ther; 1994 Mar; 268(3):1506-11. PubMed ID: 8138961
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the adenosine receptor mediating inhibition of intestinal secretion.
Hancock DL; Coupar IM
Br J Pharmacol; 1995 Jan; 114(1):152-6. PubMed ID: 7712011
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action.
Sharif NA
Curr Drug Targets; 2010 Aug; 11(8):978-93. PubMed ID: 20426763
[TBL] [Abstract][Full Text] [Related]
14. Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries.
Conti A; Lozza G; Monopoli A
Pharmacol Res; 1997 Feb; 35(2):123-8. PubMed ID: 9175581
[TBL] [Abstract][Full Text] [Related]
15. Topical application of serotonin or the 5-HT1-agonist 5-CT intraocular pressure in rabbits.
Meyer-Bothling U; Bron AJ; Osborne NN
Invest Ophthalmol Vis Sci; 1993 Sep; 34(10):3035-42. PubMed ID: 8395485
[TBL] [Abstract][Full Text] [Related]
16. Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes.
Sharif NA; McLaughlin MA; Kelly CR; Katoli P; Drace C; Husain S; Crosson C; Toris C; Zhan GL; Camras C
Exp Eye Res; 2009 Mar; 88(3):386-97. PubMed ID: 18992242
[TBL] [Abstract][Full Text] [Related]
17. Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension.
Razali N; Agarwal R; Agarwal P; Kumar S; Tripathy M; Vasudevan S; Crowston JG; Ismail NM
Clin Exp Ophthalmol; 2015; 43(1):54-66. PubMed ID: 24995479
[TBL] [Abstract][Full Text] [Related]
18. Activation of two sites by adenosine receptor agonists to cause relaxation in rat isolated mesenteric artery.
Prentice DJ; Payne SL; Hourani SM
Br J Pharmacol; 1997 Dec; 122(7):1509-15. PubMed ID: 9421303
[TBL] [Abstract][Full Text] [Related]
19. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.
Russell KR; Wang DR; Potter DE
Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526
[TBL] [Abstract][Full Text] [Related]
20. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
